2.4.0.8 HtmlAndXml 410 334 1 false 86 0 false 7 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.opexatherapeutics.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information R1.xml true false R2.htm 103 - Statement - Consolidated Balance Sheets Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets R2.xml false false R3.htm 104 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Consolidated Balance Sheets (Parenthetical) R3.xml false false R4.htm 105 - Statement - Consolidated Statements of Operations Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfIncomeAlternative Consolidated Statements of Operations R4.xml false false R5.htm 106 - Statement - Consolidated Statements of Changes In Stockholders' Equity Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements of Changes In Stockholders' Equity R5.xml false false R6.htm 107 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) R6.xml false false R7.htm 108 - Statement - Consolidated Statements of Cash Flows Sheet http://www.opexatherapeutics.com/taxonomy/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows R7.xml false false R8.htm 109 - Disclosure - Business Overview and Summary of Accounting Policies Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndAccountingPoliciesTextBlock Business Overview and Summary of Accounting Policies R8.xml false false R9.htm 110 - Disclosure - Cash and Cash Equivalents Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsCashAndCashEquivalentsDisclosureTextBlock Cash and Cash Equivalents R9.xml false false R10.htm 111 - Disclosure - Other Current Assets Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentAssetsTextBlock Other Current Assets R10.xml false false R11.htm 112 - Disclosure - Property and Equipment Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock Property and Equipment R11.xml false false R12.htm 113 - Disclosure - Income Taxes Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes R12.xml false false R13.htm 114 - Disclosure - Convertible Promissory Notes Notes http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsLongTermDebtTextBlock Convertible Promissory Notes R13.xml false false R14.htm 115 - Disclosure - Related Party Transactions Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions R14.xml false false R15.htm 116 - Disclosure - Fair Value of Derivative Financial Instruments Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value of Derivative Financial Instruments R15.xml false false R16.htm 117 - Disclosure - Commitments and Contingencies Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies R16.xml false false R17.htm 118 - Disclosure - Significant Contractual Service and Milestone Agreements Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsBusinessAndContractualArrangementsDisclosureTextBlock Significant Contractual Service and Milestone Agreements R17.xml false false R18.htm 119 - Disclosure - Equity Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Equity R18.xml false false R19.htm 120 - Disclosure - Stock-Based Compensation/Options and Warrants Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation/Options and Warrants R19.xml false false R20.htm 121 - Disclosure - Licenses and Gain on Extinguishment of Debt Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAgreementsDisclosureTextBlock Licenses and Gain on Extinguishment of Debt R20.xml false false R21.htm 122 - Disclosure - Subsequent Events Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events R21.xml false false R22.htm 123 - Disclosure - Basis of Presentation Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Basis of Presentation R22.xml false false R23.htm 124 - Disclosure - Significant Accounting Polices Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsSignificantAccountingPoliciesTextBlock Significant Accounting Polices R23.xml false false R24.htm 125 - Disclosure - Other Current Assets Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentAssetsDisclosureTextBlock Other Current Assets R24.xml false false R25.htm 126 - Disclosure - Restricted Cash Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRestrictedCashAndCashEquivalentsTextBlock Restricted Cash R25.xml false false R26.htm 127 - Disclosure - Deferred Financing Costs Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDeferredChargesDisclosureTextBlock Deferred Financing Costs R26.xml false false R27.htm 128 - Disclosure - Other Assets Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherAssetsNoncurrentDisclosureTextBlock Other Assets R27.xml false false R28.htm 129 - Disclosure - Business Overview and Summary of Accounting Policies (Policies) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsBusinessDescriptionAndAccountingPoliciesTextBlockPolicies Business Overview and Summary of Accounting Policies (Policies) R28.xml false false R29.htm 130 - Disclosure - Other Current Assets (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentAssetsTextBlockTables Other Current Assets (Tables) R29.xml false false R30.htm 131 - Disclosure - Property and Equipment (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables Property and Equipment (Tables) R30.xml false false R31.htm 132 - Disclosure - Related Party Transactions (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlockTables Related Party Transactions (Tables) R31.xml false false R32.htm 133 - Disclosure - Fair Value of Derivative Financial Instruments (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value of Derivative Financial Instruments (Tables) R32.xml false false R33.htm 134 - Disclosure - Stock-Based Compensation/Options and Warrants (Tables) Sheet http://www.opexatherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation/Options and Warrants (Tables) R33.xml false false R34.htm 135 - Disclosure - Business Overview and Summary of Accounting Policies - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureBusinessOverviewAndSummaryOfAccountingPoliciesAdditionalInformation Business Overview and Summary of Accounting Policies - Additional Information (Detail) R34.xml false false R35.htm 136 - Disclosure - Cash and Cash Equivalents - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureCashAndCashEquivalentsAdditionalInformation Cash and Cash Equivalents - Additional Information (Detail) R35.xml false false R36.htm 137 - Disclosure - Other Current Assets (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherCurrentAssets Other Current Assets (Detail) R36.xml false false R37.htm 138 - Disclosure - Other Current Assets - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherCurrentAssetsAdditionalInformation Other Current Assets - Additional Information (Detail) R37.xml false false R38.htm 139 - Disclosure - Property and Equipment (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosurePropertyAndEquipment Property and Equipment (Detail) R38.xml false false R39.htm 140 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformation Property and Equipment - Additional Information (Detail) R39.xml false false R40.htm 141 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) R40.xml false false R41.htm 142 - Disclosure - Convertible Promissory Notes - Additional Information (Detail) Notes http://www.opexatherapeutics.com/taxonomy/role/DisclosureConvertiblePromissoryNotesAdditionalInformation Convertible Promissory Notes - Additional Information (Detail) R41.xml false false R42.htm 143 - Disclosure - Summary of Changes in Convertible Debt Third Parties Net of Unamortized Discount (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfChangesInConvertibleDebtThirdPartiesNetOfUnamortizedDiscount Summary of Changes in Convertible Debt Third Parties Net of Unamortized Discount (Detail) R42.xml false false R43.htm 144 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation Related Party Transactions - Additional Information (Detail) R43.xml false false R44.htm 145 - Disclosure - Summary of Changes in Convertible Debt Related Parties Net of Unamortized Discount (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfChangesInConvertibleDebtRelatedPartiesNetOfUnamortizedDiscount Summary of Changes in Convertible Debt Related Parties Net of Unamortized Discount (Detail) R44.xml false false R45.htm 146 - Disclosure - Fair Value of Derivatives Financial Instruments - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureFairValueOfDerivativesFinancialInstrumentsAdditionalInformation Fair Value of Derivatives Financial Instruments - Additional Information (Detail) R45.xml false false R46.htm 147 - Disclosure - Changes in Fair Value of Derivative Financial Instruments Measured at Fair Value on Recurring Basis using Significant Unobservable Inputs (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureChangesInFairValueOfDerivativeFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisUsingSignificantUnobservableInputs Changes in Fair Value of Derivative Financial Instruments Measured at Fair Value on Recurring Basis using Significant Unobservable Inputs (Detail) R46.xml false false R47.htm 148 - Disclosure - Variables used in Lattice Option Pricing Model for Derivative Liabilities (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureVariablesUsedInLatticeOptionPricingModelForDerivativeLiabilities Variables used in Lattice Option Pricing Model for Derivative Liabilities (Detail) R47.xml false false R48.htm 149 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) R48.xml false false R49.htm 150 - Disclosure - Significant Contractual Service and Milestone Agreements - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSignificantContractualServiceAndMilestoneAgreementsAdditionalInformation Significant Contractual Service and Milestone Agreements - Additional Information (Detail) R49.xml false false R50.htm 151 - Disclosure - Equity - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureEquityAdditionalInformation Equity - Additional Information (Detail) R50.xml false false R51.htm 152 - Disclosure - Stock-Based Compensation/Options and Warrants - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationOptionsAndWarrantsAdditionalInformation Stock-Based Compensation/Options and Warrants - Additional Information (Detail) R51.xml false false R52.htm 153 - Disclosure - Summary Information Regarding Options and Warrants (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryInformationRegardingOptionsAndWarrants Summary Information Regarding Options and Warrants (Detail) R52.xml false false R53.htm 154 - Disclosure - Summary of Options Outstanding and Exercisable (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfOptionsOutstandingAndExercisable Summary of Options Outstanding and Exercisable (Detail) R53.xml false false R54.htm 155 - Disclosure - Summary of Warrant Outstanding and Exercisable (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSummaryOfWarrantOutstandingAndExercisable Summary of Warrant Outstanding and Exercisable (Detail) R54.xml false false R55.htm 156 - Disclosure - Licenses and Gain on Extinguishment of Debt - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureLicensesAndGainOnExtinguishmentOfDebtAdditionalInformation Licenses and Gain on Extinguishment of Debt - Additional Information (Detail) R55.xml false false R56.htm 157 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation Subsequent Events - Additional Information (Detail) R56.xml false false R57.htm 158 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformation Significant Accounting Policies - Additional Information (Detail) R57.xml false false R58.htm 159 - Disclosure - Restricted Cash - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureRestrictedCashAdditionalInformation Restricted Cash - Additional Information (Detail) R58.xml false false R59.htm 160 - Disclosure - Deferred Financing Costs - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureDeferredFinancingCostsAdditionalInformation Deferred Financing Costs - Additional Information (Detail) R59.xml false false R60.htm 161 - Disclosure - Other Assets - Additional Information (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureOtherAssetsAdditionalInformation Other Assets - Additional Information (Detail) R60.xml false false R61.htm 162 - Disclosure - Stock Option Activity (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureStockOptionActivity Stock Option Activity (Detail) R61.xml false false R62.htm 163 - Disclosure - Warrant Activity (Detail) Sheet http://www.opexatherapeutics.com/taxonomy/role/DisclosureWarrantActivity Warrant Activity (Detail) R62.xml false false All Reports Book All Reports Element opxa_ExpectedFuturePayments had a mix of decimals attribute values: -5 0. Element us-gaap_ContractsRevenue had a mix of decimals attribute values: -6 0. Element us-gaap_MoneyMarketFundsAtCarryingValue had a mix of decimals attribute values: -5 0. 'Shares' elements on report '135 - Disclosure - Business Overview and Summary of Accounting Policies - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '135 - Disclosure - Business Overview and Summary of Accounting Policies - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '141 - Disclosure - Income Taxes - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '157 - Disclosure - Subsequent Events - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: Removing column 'Dec. 31, 2008' Process Flow-Through: Removing column 'Dec. 31, 2007' Process Flow-Through: Removing column 'Dec. 31, 2006' Process Flow-Through: Removing column 'Dec. 31, 2005' Process Flow-Through: Removing column 'Dec. 31, 2004' Process Flow-Through: Removing column 'Dec. 31, 2003' Process Flow-Through: 104 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: Removing column 'Dec. 14, 2012' Process Flow-Through: 105 - Statement - Consolidated Statements of Operations Process Flow-Through: Removing column '11 Months Ended Dec. 31, 2003' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2008' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2006' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2005' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2004' Process Flow-Through: 107 - Statement - Consolidated Statements of Changes In Stockholders' Equity (Parenthetical) Process Flow-Through: 108 - Statement - Consolidated Statements of Cash Flows opxa-20130331.xml opxa-20130331.xsd opxa-20130331_cal.xml opxa-20130331_def.xml opxa-20130331_lab.xml opxa-20130331_pre.xml true true